Chocolate Recall Update As FDA Sets Highest Risk Level for 9 States
FDA upgrades Frito-Lay potato chips recall to highest risk level due to undeclared milk
Lay’s potato chip recall elevated to FDA’s highest-risk classification
Did RFK Jr.’s Lawyer Ask the FDA to Revoke Approval for the Polio Vaccine?
Aaron Siri, a lawyer advising Robert F. Kennedy Jr. as he prepared to become health secretary, petitioned the Food and Drug Administration in 2022 to revoke approval of a polio vaccine that is used widely in the U.
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
FDA Approves Ozempic to Treat Kidney Disease
 · 1hMcKnight's Long-Term Care News
FDA expands Ozempic to treat kidney disease in people with diabetes
The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, prevent death from cardiovascular disease,
Sorbet Recall Update As FDA Sets Highest Risk Level
A sorbet-filled mochi recalled due to an undeclared allergen has been given the U.S. Food and Drug Administration (FDA)'s highest risk level. The My Mochi Ice Cream Company of Vernon, California, recalled 1,
Walmart broccoli recall elevated to highest level by FDA over risk of ‘death’
Broccoli packages sold at Walmart stores in 20 states have received an elevated recall status over a Listeria contamination that has potentially fatal consequences.
Lay's potato chips recall upgraded to FDA's most serious level. Is Ohio affected?
The FDA elevated Lay's Classic Potato Chips to the highest risk level. Here what to know, and whether the recall impacts Ohio.
Ticker: FDA puts out alarming chocolate recall; Tesla’s fourth-quarter results fall short; Meta posts sharply higher Q4 profit
Ticker: FDA puts out alarming chocolate recall; Tesla’s fourth-quarter results fall short; Meta posts sharply higher Q4 profit
Lay's Potato Chip Recall Raised to Highest Risk as FDA Warns of 'Death'
The FDA has issued a Class I recall for Lay’s Classic Potato Chips due to undeclared milk, warning of severe allergic reactions or death.
FDA approves medication for sleep apnea
The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence that GLP-1 drugs improve overall health along with weight loss.
The American Spectator2h
Trump: Look at the Slow-Moving FDA
The U.S. Food and Drug Administration’s recent approval of a product known as Zyn is a leap forward for the cause of tobacco harm
NeuroPace's SWOT analysis: epilepsy device maker's stock poised for growth
NeuroPace, Inc. (NASDAQ:NPCE), a medical device company specializing in neurological disorders with a market capitalization of $439 million, has been making significant strides in the epilepsy treatment market with its Responsive Neurostimulation (RNS) System.
Hosted on MSN5h
Phase III Trials: It’s crunch time for these ASX health stocks
Several ASX-listed companies are undertaking phase III clinical trials, the critical final stage before potential regulatory approval. ... Read More The post Phase III Trials: It’s crunch time for these ASX health stocks appeared first on Stockhead.